Literature DB >> 10606174

Prognostic relevance of TP53 mutations, p53 protein, Ki-67 index and conventional histological grading in oligodendrogliomas.

C Hagel1, B Krog, R Laas, D K Stavrou.   

Abstract

The prognostic value of tumour grading according to WHO, Ki-67 proliferation index, p53 labelling index and TP53 gene mutations was assessed in 59 patients (33 oligodendrogliomas WHO grade II, 15 anaplastic oligodendrogliomas, 11 glioblastomas with oligodendroglial growth pattern). The minimal observation period was 5 years after operation. According to multivariate correlation and regression tree (CART) analysis grading was the prime prognostic factor (grade II vs. anaplastic tumours, p < 0.00001). Grade II oligodendrogliomas were further divided into tumours with and without TP53 mutations (p < 0.05) whereas anaplastic tumours were subdivided according to age (p < 0.05, cut off at 57 years) and p53 protein accumulation (p < 0.05, cut off at 2%, age 57 years). Ki-67 labelling index correlated highly significantly with grading but had no independent prognostic relevance in CART analysis. Accumulation of wild-type p53 protein was not related to bcl-2 expression, a co-expression of p53 and bcl-2 was found at similar frequencies in tumours with or without TP53 mutations (4/12 vs. 3/11). Since accumulation of wild-type and mutant p53 are both associated with a poor prognosis, it is suggested to include immunohistochemical evaluation of p53 protein in routine diagnostics of oligodendrogliomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10606174

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  5 in total

1.  The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma. An analysis of 91 cases.

Authors:  A Korshunov; A Golanov
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Polysomy of chromosomes 1 and 19: an underestimated prognostic factor in oligodendroglial tumors.

Authors:  Haihui Jiang; Xiaohui Ren; Zhe Zhang; Wei Zeng; Junmei Wang; Song Lin
Journal:  J Neurooncol       Date:  2014-07-10       Impact factor: 4.130

3.  Immunohistochemical markers for prognosis of oligodendroglial neoplasms.

Authors:  Andrey Korshunov; Andrey Golanov; Regina Sycheva
Journal:  J Neurooncol       Date:  2002-07       Impact factor: 4.130

4.  Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q loss.

Authors:  Matija Snuderl; April F Eichler; Keith L Ligon; Quynh U Vu; Michael Silver; Rebecca A Betensky; Azra H Ligon; Patrick Y Wen; David N Louis; A John Iafrate
Journal:  Clin Cancer Res       Date:  2009-10-06       Impact factor: 12.531

5.  Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumors.

Authors:  Hui Chen; Cheddhi Thomas; Felipe Andres Munoz; Sanda Alexandrescu; Craig M Horbinski; Adriana Olar; Declan McGuone; Sandra Camelo-Piragua; Lu Wang; Elena Pentsova; Joanna Phillips; Kenneth Aldape; Wen Chen; A John Iafrate; Andrew S Chi; David Zagzag; John G Golfinos; Dimitris G Placantonakis; Marc Rosenblum; Pamela Ohman-Strickland; Meera Hameed; Matija Snuderl
Journal:  Neuro Oncol       Date:  2019-09-06       Impact factor: 13.029

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.